Sandra Bien-Möller

573 total citations
19 papers, 403 citations indexed

About

Sandra Bien-Möller is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Sandra Bien-Möller has authored 19 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Genetics. Recurrent topics in Sandra Bien-Möller's work include Glioma Diagnosis and Treatment (4 papers), Sphingolipid Metabolism and Signaling (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Sandra Bien-Möller is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Sphingolipid Metabolism and Signaling (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Sandra Bien-Möller collaborates with scholars based in Germany, United States and Switzerland. Sandra Bien-Möller's co-authors include Henry W. S. Schroeder, Bernhard H. Rauch, Sascha Marx, Susann Herzog, Silke Vogelgesang, Markus Grube, Wolfgang Hoffmann, Kerstin Weitmann, Matthias A. Fink and Shailaja G. Mahajan and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Sandra Bien-Möller

17 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Bien-Möller Germany 12 235 108 87 73 52 19 403
Monica Cubillos‐Rojas Spain 14 426 1.8× 131 1.2× 65 0.7× 49 0.7× 57 1.1× 25 611
Susana Zuluaga Spain 9 338 1.4× 85 0.8× 66 0.8× 24 0.3× 68 1.3× 9 450
Linfang Wang China 13 312 1.3× 133 1.2× 91 1.0× 38 0.5× 62 1.2× 37 575
Daniela Di Marcantonio United States 15 417 1.8× 148 1.4× 66 0.8× 48 0.7× 37 0.7× 29 569
Andreas R. Baudy United States 10 343 1.5× 90 0.8× 135 1.6× 33 0.5× 21 0.4× 12 528
Mireia Nàger Spain 11 346 1.5× 73 0.7× 78 0.9× 59 0.8× 65 1.3× 15 480
Shweta Tiwary United States 10 433 1.8× 117 1.1× 221 2.5× 40 0.5× 41 0.8× 12 597
Cécile Thirant France 13 408 1.7× 141 1.3× 170 2.0× 114 1.6× 32 0.6× 18 594
Anastasia A. Khutornenko Russia 10 345 1.5× 50 0.5× 99 1.1× 51 0.7× 28 0.5× 13 465
Jacqueline Sayyah United States 9 368 1.6× 178 1.6× 78 0.9× 67 0.9× 21 0.4× 11 534

Countries citing papers authored by Sandra Bien-Möller

Since Specialization
Citations

This map shows the geographic impact of Sandra Bien-Möller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Bien-Möller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Bien-Möller more than expected).

Fields of papers citing papers by Sandra Bien-Möller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Bien-Möller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Bien-Möller. The network helps show where Sandra Bien-Möller may publish in the future.

Co-authorship network of co-authors of Sandra Bien-Möller

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Bien-Möller. A scholar is included among the top collaborators of Sandra Bien-Möller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Bien-Möller. Sandra Bien-Möller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bien-Möller, Sandra, et al.. (2025). Case report of three patients with end-stage recurrent glioblastoma treated with meldonium. PubMed. 3(1). 29–29.
2.
Bien-Möller, Sandra, Jan Albrecht, Kerstin Weitmann, et al.. (2025). The protease-activated receptors are expressed in glioblastoma and differentially modulate adherent versus stem-like growth of LN-18 GBM cells. Frontiers in Oncology. 15. 1582996–1582996.
3.
Bien-Möller, Sandra, Fan Chen, Yong Xiao, et al.. (2023). The Putative S1PR1 Modulator ACT-209905 Impairs Growth and Migration of Glioblastoma Cells In Vitro. Cancers. 15(17). 4273–4273. 3 indexed citations
4.
Marx, Sascha, Lea Miebach, Sandra Bien-Möller, et al.. (2022). Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma Patients. Cancers. 14(23). 5751–5751. 6 indexed citations
5.
Bien-Möller, Sandra, Sascha Marx, Sander Bekeschus, et al.. (2022). Devitalization of Glioblastoma Cancer Cells by Non-invasive Physical Plasma: Modulation of Proliferative Signalling Cascades. Anticancer Research. 43(1). 7–18. 10 indexed citations
6.
Moritz, Eileen, Robert H. Wolf, Sascha Marx, et al.. (2022). Platelet-Derived S1P and Its Relevance for the Communication with Immune Cells in Multiple Human Diseases. International Journal of Molecular Sciences. 23(18). 10278–10278. 9 indexed citations
7.
Herzog, Susann, Matthias A. Fink, Markus Grube, et al.. (2021). PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells. International Journal of Molecular Sciences. 22(20). 11126–11126. 16 indexed citations
8.
Schwabedissen, Henriette E. Meyer zu, et al.. (2020). OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists. Molecular Pharmaceutics. 17(6). 1987–1995. 26 indexed citations
9.
Fink, Matthias A., Susann Herzog, Markus Grube, et al.. (2019). L -Carnitine–Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme. Clinical Cancer Research. 25(9). 2874–2886. 44 indexed citations
10.
Marx, Sascha, Yong Xiao, Eileen Moritz, et al.. (2019). The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma. Cancers. 11(4). 569–569. 24 indexed citations
11.
Bien-Möller, Sandra, Susann Herzog, Silke Vogelgesang, et al.. (2018). Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival. Stem Cells International. 2018. 1–19. 36 indexed citations
12.
Marx, Sascha, Eileen Moritz, Christy Joseph, et al.. (2018). Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients. Oncotarget. 9(40). 25860–25876. 11 indexed citations
13.
Budde, Thomas, Henriette E. Meyer zu Schwabedissen, Sandra Bien-Möller, et al.. (2017). Doxorubicin enhances oxysterol levels resulting in a LXR-mediated upregulation of cardiac cholesterol transporters. Biochemical Pharmacology. 144. 108–119. 12 indexed citations
14.
Mahajan, Shailaja G., Sandra Bien-Möller, Sascha Marx, Henry W. S. Schroeder, & Bernhard H. Rauch. (2017). Sphingosine 1-Phosphate (S1P) Signaling in Glioblastoma Multiforme—A Systematic Review. International Journal of Molecular Sciences. 18(11). 2448–2448. 45 indexed citations
15.
Bien-Möller, Sandra, Sandra Lange, Andreas Böhm, et al.. (2016). Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme. Oncotarget. 7(11). 13031–13046. 36 indexed citations
16.
Ameling, Sabine, Elke Hammer, Stefan Oswald, et al.. (2015). Protective effects of endothelin receptor A and B inhibitors against doxorubicin-induced cardiomyopathy. Biochemical Pharmacology. 94(2). 109–129. 25 indexed citations
17.
Hammer, Elke, Sandra Bien-Möller, Anja Geisler, et al.. (2014). A Novel Artificial MicroRNA Expressing AAV Vector for Phospholamban Silencing in Cardiomyocytes Improves Ca2+ Uptake into the Sarcoplasmic Reticulum. PLoS ONE. 9(3). e92188–e92188. 17 indexed citations
18.
Bien-Möller, Sandra, Kerstin Weitmann, Susann Herzog, et al.. (2013). Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme. BMC Cancer. 13(1). 617–617. 41 indexed citations
19.
Foerster, Sarah, Tim Kacprowski, Vishnu M. Dhople, et al.. (2013). Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics. PROTEOMICS. 13(21). 3131–3144. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Cubillos‐Rojas Breakdown of academic impact, for papers by Susana Zuluaga Breakdown of academic impact, for papers by Linfang Wang Breakdown of academic impact, for papers by Daniela Di Marcantonio Breakdown of academic impact, for papers by Andreas R. Baudy Breakdown of academic impact, for papers by Mireia Nàger Breakdown of academic impact, for papers by Shweta Tiwary Breakdown of academic impact, for papers by Cécile Thirant Breakdown of academic impact, for papers by Anastasia A. Khutornenko Breakdown of academic impact, for papers by Jacqueline Sayyah
Rankless by CCL
2026